Prednisone Regimen for Bronchitis
For severe paroxysms of postinfectious cough in bronchitis, a short course of prednisone at 30-40 mg per day for 5 days is recommended when other common causes of cough have been ruled out. 1
Understanding Bronchitis and the Role of Corticosteroids
Bronchitis can be classified as acute or chronic, with different treatment approaches for each:
Acute/Postinfectious Bronchitis
- Most cases are viral in origin and self-limited
- Antibiotics have no role in treatment unless bacterial infection is confirmed 1
- Initial management should focus on:
When to Consider Systemic Corticosteroids
Systemic corticosteroids (prednisone) should be considered in these specific situations:
Severe paroxysmal cough in postinfectious bronchitis:
- Dosage: 30-40 mg prednisone daily
- Duration: Short, finite period (5 days)
- Prerequisites: Rule out other common causes of cough (upper airway cough syndrome, asthma, GERD) 1
COPD exacerbations:
Important Considerations and Caveats
Do not use corticosteroids for bronchiolitis in children: Evidence shows no clinical benefit and potential for adverse effects 1
Antibiotics should only be used when indicated by:
- Increased sputum purulence
- Increased dyspnea
- Bacterial infection confirmed 1
Central-acting antitussive agents (codeine, dextromethorphan) should be considered only when other measures fail 1, 2
Treatment Algorithm for Bronchitis
First-line treatment:
If cough persists despite ipratropium:
- Add inhaled corticosteroids 1
For severe paroxysmal cough:
- Add prednisone 30-40 mg daily for 5 days 1
- Monitor for improvement in symptoms
If purulent sputum present:
- Consider appropriate antibiotics 1
For refractory symptoms:
Special Considerations
- Patients with sputum eosinophilia may be more likely to respond to corticosteroid therapy 3
- Patients with underlying COPD or asthma may require different management approaches
- Longer courses of oral corticosteroids are not recommended due to side effect profiles 1
Remember that the primary goal of treatment is to improve morbidity, mortality, and quality of life by addressing the underlying cause of bronchitis and managing symptoms effectively.